Creatinine Assay Kits Market Inclinations and Development Status Highlighted During Forecast Period

SDKI Inc. published a new report on the Creatinine Assay Kit Market-Global Forecast 2030. This study includes the statistical and analytical approaches needed to grow the creatinine assay kit market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-109534

The creatinine assay kit market is estimated to grow from a market value of US $ 245.4 million in 2022 to US $ 352.2 million by 2030, with a CAGR of 5.3% during the forecast period.

The creatinine assay kit is used to measure creatinine levels in serum / plasma, urine, and other biological samples. Creatinine is a waste product produced by muscles by the breakdown of creatine compounds, which is removed from the body by the kidneys, filtered from the blood and released into the urine. Creatinine assays are used to analyze protein metabolism in the body, and creatinine levels can be affected by changes in muscle mass, pregnancy, cancer, and more.

Growth in this market is driven primarily by an increase in the incidence of renal disorders and the incidence of other chronic disorders that affect renal function. Increasing awareness and adoption of preventive medicine approaches and the implementation of favorable government initiatives to promote kidney health are expected to boost market growth during the forecast period. In addition, the rapid growth of the aged population and advances in biomedical research related to kidney damage are also contributing to market growth. However, the limited use of creatinine assay kits in IVD and the identification of new renal dysfunction biomarkers are expected to curb market growth in the coming years.

Market segment

The creatinine assay kit market is divided by type (Jaffe's dynamic test kit, creatinine-PAP test kit, and ELISA test kit), by sample (blood, serum, urine, saliva, CSF, tissue homogenate, sweat) and by region. Will be. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The creatinine-PAP test kit is expected to grow at a maximum CAGR during the forecast period.

Based on the type, the market is divided into Jaffe's dynamic test kits, creatinine-PAP test kits, and ELISA test kits. The creatinine-PAP test kit segment is expected to grow at a maximum CAGR during the forecast period. The fastest growth in this segment is due to the growing demand for more accurate kits and the high research funding support for the kidney research initiative.

The urine segment is expected to dominate the market during the forecast period.

Based on the samples, the creatinine assay kit market is divided into blood / serum, urine, and other samples. The urine segment is expected to dominate the market during the forecast period. The large share of this segment may be primarily due to the preference for urine samples due to the ease of sample collection.

Area overview

The creatinine assay kit market is further subdivided based on region and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions.

In 2017, North America has the largest share of the market, followed by Europe. However, the Asia Pacific region is expected to register the largest CAGR during the forecast period. The high prevalence of CKD and ESRD in the region, and the presence of a large undiagnosed population, are key factors driving the growth of the creatinine assay kit market in the region. In addition, the increased prevalence of infectious diseases and metabolic syndrome in the region has led to regular prescriptions for metabolic testing. This is expected to drive market growth in the region.

Major key players on the market

Key players in the creatinine assay kit market include Thermo Fisher Scientific (US), Merck (Germany), Abcam (UK), Abbott Laboratories (US), Quidel (US), Enzo Life Sciences (US), and Cayman Chemical (US). US), Crystal Chem (US), Cell Biolabs (US), GenWay Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), Arbor Assays (US) )And so on. This study includes in-depth competitive analysis, company profiles, recent developments, and key market strategies for these leading companies in the creatinine assay kit market.

Details of the survey report
https://www.sdki.jp/reports/creatinine-assay-kits-market/109534

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.